YZYisheng Zhang

Yisheng Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yisheng Zhang has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Fuyan Wang

    Zhejiang Provincial Key Laboratory of Pathophysiology, Diabetes Research Center, Medical School of Ningbo University, Ningbo, Zhejiang, China

    2 shared publications
  • Hangyu Wu

    Zhejiang Provincial Key Laboratory of Pathophysiology, Diabetes Research Center, Medical School of Ningbo University, Ningbo, Zhejiang, China

    2 shared publications
  • Jiali Chen

    Department of Obstetrics, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, P. R. China

    2 shared publications
  • Mei Ye

    2 shared publications
  • Miaojun Lai

    Zhejiang Provincial Key Lab of Addiction Research, The Affiliated Kangning Hospital of Ningbo University, Ningbo, P. R. China

    2 shared publications
  • Shizhong Bu

    2 shared publications

Latest Publications

  • Open Access

    Impact of Labor Analgesia on Delivery Outcomes in Parturients With Gestational Diabetes Mellitus

    by Yi Zheng, Mingyan Sheng, Xiaoyan Lu, Ming Wang, Zao Cen, Yisheng Zhang

    Aims/Background: Although the efficacy of labor analgesia in pain relief is well-established, its impact on labor progression and maternal-neonatal outcomes remains inconclusive, particularly in parturients with gestational diabetes mellitus (GDM). This study aimed to examine the effects of labor analgesia on labor progression, delivery mode, and neonatal outcomes in parturients with GDM, thereby providing evidence to optimize clinical intervention strategies. Methods: A total of 201 GDM parturients meeting inclusion criteria at Beilun District People’s Hospital of Ningbo City between 1 January 2023 and 31 December 2024, were retrospectively analyzed. Participants were allocated to the observation group (labor analgesia, n = 111) or the control group (routine delivery, n = 90) based on whether they received labor analgesia. Maternal clinical data, delivery mode, labor duration, maximum intrapartum temperature, postpartum hemorrhage, neonatal Apgar scores, and other obstetric outcomes were compared and analyzed retrospectively. Statistical analyses included independent sample t-tests, Mann–Whitney U test, Chi-squared tests, and Chi-squared correction. Results: Among the 111 parturients receiving labor analgesia, the 2-hour capillary blood glucose variation during labor was significantly higher in the epidural analgesia (EP) group compared with the combined spinal-epidural analgesia (CSEA) group (p < 0.001). The postpartum fasting plasma glucose (FPG) difference was also significantly greater (p < 0.001). The numerical rating scale (NRS) score after EP in the observation group was markedly lower than the pre-analgesia score (p < 0.001). The observation group demonstrated longer first and second stages of labor (p < 0.05), lower 2-hourly glucose fluctuations, higher maximum intrapartum temperature (p < 0.05) and soft tissue lacerations (p < 0.05), and increased rates of oxytocin use and episiotomy (p < 0.05). Furthermore, urinary ketone positivity, FPG difference, and 2-hour postprandial blood glucose (2hPBG) difference were lower in the observation group (p < 0.05), whereas postpartum day 1 C-reactive protein (CRP) levels were higher (p < 0.05). No significant differences were observed in delivery mode, postpartum urinary retention, postpartum hemorrhage, neonatal clavicle fracture, neonatal transfer, or incidence of patent foramen ovale and ductus arteriosus (p > 0.05). Conclusion: Labor analgesia effectively alleviates labor pain and stabilizes intrapartum blood glucose fluctuations without increasing the risk of cesarean delivery or adverse maternal-neonatal outcomes. However, it may prolong labor duration, elevate intrapartum temperature, and increase oxytocin use, as well as the rates of episiotomy and soft birth canal lacerations. For GDM parturients receiving labor analgesia, close monitoring and management of blood glucose, uterine contractions, and labor progression are essential to minimize potential risks associated with vaginal delivery.

  • Open Access

    Antidepressant effects of activation of infralimbic cortex via upregulation of BDNF and β-catenin in an estradiol withdrawal model

    by Jiali Chen, Yiying Zhou, Miaojun Lai, Yanping Zhang, Yifang Hu, Dingding Zhuang, Wenhua Zhou, Yisheng Zhang

    Rationale: Clinical and preclinical studies have demonstrated that estradiol withdrawal after delivery is one of important factors involved in the pathogenesis of postpartum depression (PPD). The infralimbic cortex (IL) is related to anxiety and mood disorders. Whether IL neurons mediate PPD is still unclear. Objectives: This study was to observe the antidepressant effect and expression of BDNF and β-catenin in IL by allopregnanolone (ALLO) treatment or the selective activation or inhibition of IL neurons using a chemogenetic approach in a pseudopregnancy model of PPD. Methods: Administration of estradiol combined with progesterone and the abrupt withdrawal of estradiol simulated the pregnancy and early postpartum periods to induce depression in ovariectomized rats. The relative expression levels of β-catenin and BDNF were observed by western blotting. Results: Immobility time was significantly increased in the forced swim test and open-arm movement was reduced in the elevated plus maze test in the estradiol-withdrawn rats. After ALLO treatment, the immobility time were lower and open-arm traveling times higher than those of the estradiol-withdrawn rats. Meanwhile, the expression level of BDNF or β-catenin in the IL was reduced significantly in estradiol-withdrawn rats, which was prevented by treatment with ALLO. The hM3Dq chemogenetic activation of pyramidal neurons in the IL reversed the immobility and open-arm travel time trends in the estradiol-withdrawal rat model, but chemogenetic inhibition of IL neurons failed to affect this. Upregulated BDNF and β-catenin expression and increased c-Fos in the basolateral amygdala were found following IL neuron excitation in model rats. Conclusions: Our results demonstrated that pseudopregnancy and estradiol withdrawal produced depressive-like behavior and anxiety. ALLO treatment or specific excitement of IL pyramidal neurons relieved abnormal behaviors and upregulated BDNF and β-catenin expression in the IL in the PPD model, suggesting that hypofunction of IL neurons may be involved in the pathogenesis of PPD.


  • Open Access

    Polypyrimidine tract binding protein knockdown reverses depression-like behaviors and cognition impairment in mice with lesioned cholinergic neurons

    by Yiying Zhou, Ke Zhang, Fangmin Wang, Jiali Chen, Shanshan Chen, Manqing Wu, Miaojun Lai, Yisheng Zhang, Wenhua Zhou

    Background and objectives: Depression is a common comorbidity of dementia and may be a risk factor for dementia. Accumulating evidence has suggested that the cholinergic system plays a central role in dementia and depression, and the loss of cholinergic neurons is associated with memory decline in aging and Alzheimer’s patients. A specific loss of cholinergic neurons in the horizontal limb of the diagonal band of Broca (HDB) is correlated with depression and dysfunction of cognition in mice. In this study, we examined the potential regenerative mechanisms of knockdown the RNA-binding protein polypyrimidine tract binding protein (PTB) in reversing depression-like behaviors and cognition impairment in mice with lesioned cholinergic neurons.Methods: We lesioned cholinergic neurons in mice induced by injection of 192 IgG-saporin into HDB; then, we injected either antisense oligonucleotides or adeno-associated virus-shRNA (GFAP promoter) into the injured area of HDB to deplete PTB followed by a broad range of methodologies including behavioral examinations, Western blot, RT-qPCR and immunofluorescence.Results: We found that the conversion of astrocytes to newborn neurons by using antisense oligonucleotides on PTB in vitro, and depletion of PTB using either antisense oligonucleotides or adeno-associated virus-shRNA into the injured area of HDB could specifically transform astrocytes into cholinergic neurons. Meanwhile, knockdown of PTB by both approaches could relieve the depression-like behaviors shown by sucrose preference, forced swimming or tail-suspension tests, and alleviate cognitive impairment such as fear conditioning and novel object recognition in mice with lesioned cholinergic neurons.Conclusion: These findings suggest that supplementing cholinergic neurons after PTB knockdown may be a promising therapeutic strategy to revert depression-like behaviors and cognitive impairment.


  • Circulating miRNAs miR-574-5p and miR-3135b are potential metabolic regulators for serum lipids and blood glucose in gestational diabetes mellitus

    by Fuyan Wang, Zhulin Li, Ming Zhao, Wen Ye, Hangyu Wu, Qi Liao, Shizhong Bu, Yisheng Zhang

    MicroRNAs (miRNAs) are potentially involved in the regulation of glucose and lipid metabolism. The aim of this study was to investigate potential miRNA regulators for serum lipids and blood glucose...


  • Root bark of Morus alba ameliorates the depressive-like behaviors in diabetic rats

    by Mei Ye, Yuting Ke, Bingyang Liu, Yanyan Yuan, Fuyan Wang, Shizhong Bu, Yisheng Zhang